Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of ANH on Coagulation in Cardiac Surgery
NCT06664320Not yet recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- Oct 2024
- Primary completion
- Mar 2025
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hetastarch in mitral regurgitation (MR), mitral stenosis (MS) and tricuspid regurgitation (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Maximal Clot Firmness of EXTEM. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
hetastarch
03
Conditions
mitral regurgitation (MR)mitral stenosis (MS)tricuspid regurgitation
Beyond the preview
Go deeper on NCT06664320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06664320.